Lantern Pharma Inc. (LTRN) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-04-03
10:53 am
Purchase
2026-03-3013GLANTERN PHARMA INC
LTRN
Thomas A. Satterfield, Jr.570,000
5.100%
570,000increase
(New Position)
Filing
History
2026-02-23
4:37 pm
Sale
2026-02-2013DLANTERN PHARMA INC
LTRN
BIOS EQUITY PARTNERS, LP960,026
8.580%
-115,926decrease
(-10.77%)
Filing
History
2025-06-13
7:43 pm
Sale
2025-06-1213DLANTERN PHARMA INC
LTRN
BIOS EQUITY PARTNERS, LP1,075,952
9.980%
-187,850decrease
(-14.86%)
Filing
History
2024-03-01
4:10 pm
Sale
2024-02-2813DLANTERN PHARMA INC
LTRN
BIOS EQUITY PARTNERS, LP1,263,802
11.800%
-202,889decrease
(-13.83%)
Filing
History
2024-02-14
4:05 pm
Sale
2023-12-3113GLANTERN PHARMA INC
LTRN
ProPhase Labs Inc.
PRPH
631,195
5.800%
-278,805decrease
(-30.64%)
Filing
History
2023-12-01
06:02 am
Sale
2023-11-2913DLANTERN PHARMA INC
LTRN
BIOS EQUITY PARTNERS, LP1,466,691
13.600%
-508,150decrease
(-25.73%)
Filing
History
2022-11-21
4:15 pm
Purchase
2022-11-0813GLANTERN PHARMA INC
LTRN
ProPhase Labs Inc.
PRPH
910,000
8.400%
910,000increase
(New Position)
Filing
History
2022-03-22
4:15 pm
Purchase
2022-03-1713DLANTERN PHARMA INC
LTRN
BIOS EQUITY PARTNERS, LP1,974,841
18.100%
5,855increase
(+0.30%)
Filing
History
2022-01-11
10:31 am
Sale
2021-12-3113GLANTERN PHARMA INC
LTRN
Empery Asset Management LP0
0.000%
-700,000decrease
(Position Closed)
Filing
History